Login / Signup

Systemic Pseudohypoaldosteronism Type I: A Case Report and Review of the Literature.

Nasifa NurCameron LangJuanita K HodaxJose Bernardo Quintos
Published in: Case reports in pediatrics (2017)
Systemic pseudohypoaldosteronism (PHA) type I is a rare genetic disorder resulting from mutations in the subunits of the epithelial sodium channel that manifests as severe salt wasting, hyperkalemia, and metabolic acidosis in infancy. In this article we report a patient with systemic PHA type I presenting with severe dehydration due to salt wasting at 6 days of life. She was found to have a known mutation in the SCNN1A gene and subsequently required treatment with sodium supplementation. We also review the clinical presentation, differential diagnosis, and treatment of systemic PHA type I and summarize data from 27 cases with follow-up data.
Keyphrases
  • electronic health record
  • genome wide
  • case report
  • early onset
  • drug induced
  • copy number
  • big data
  • gene expression
  • dna methylation
  • transcription factor
  • combination therapy
  • smoking cessation